argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
31 may 2022 - 07:06
Statutory name
argenx SE
Title
argenx Announces the UK MHRA has Granted Early Access to Efgartigimod for Generalized Myasthenia Gravis
Date last update: 06 October 2026